We understand that it can be challenging to gain clarity and perspective on breaking Parkinson's news. Q&As in this section are conducted with leading experts in the Parkinson's disease research field to quickly provide an informed, impartial opinion on new findings -- and to get to the bottom of what they might mean for researchers and people living with PD today.
January 14, 2014
Recently researchers from Beth Israel Deaconess Medical Center in Boston published a paper in Neurology on their findings that alpha-synuclein levels in nerve cells found in the skin differed between Parkinson's patients and healthy controls. We talked to Roy Freeman, MD, lead author on the paper, about his team's study and what this could mean in the pursuit of a Parkinson's biomarker. Biomarkers are objective measures of disease risk, presence or progression that, as Roy tells us, could have m...Read More